ProfileGDS4718 / 1554086_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 40% 41% 35% 41% 38% 61% 60% 45% 49% 46% 44% 42% 56% 60% 59% 55% 45% 61% 59% 44% 41% 50% 53% 51% 42% 53% 39% 54% 41% 50% 50% 57% 41% 50% 65% 53% 52% 44% 47% 41% 43% 54% 46% 49% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.9898340
GSM549102patient 115, normal, homogenized [OPG study]5.0852241
GSM549104patient 119, normal, homogenized [OPG study]4.7372335
GSM549108patient 138, normal, homogenized [OPG study]5.1021541
GSM549119patient 077, normal, homogenized [OPG study]4.8860738
GSM549133patient 032, cancer, homogenized [OPG study]6.2037161
GSM549139patient 042, cancer, homogenized [OPG study]6.1485760
GSM549099patient 107, normal, homogenized [OPG study]5.252345
GSM549109patient 139, normal, homogenized [OPG study]5.4544949
GSM549110patient 046, normal, homogenized [OPG study]5.2724346
GSM549114patient 063, normal, homogenized [OPG study]5.1481344
GSM549122patient 082, normal, homogenized [OPG study]5.0908242
GSM549134patient 033, cancer, homogenized [OPG study]5.8238256
GSM549136patient 036, cancer, homogenized [OPG study]6.0846160
GSM549140patient 044, cancer, homogenized [OPG study]6.0206259
GSM549111patient 047, normal, homogenized [OPG study]5.7785655
GSM549113patient 057, normal, homogenized [OPG study]5.2062945
GSM549132patient 031, cancer, homogenized [OPG study]6.1815861
GSM549137patient 038, cancer, homogenized [OPG study]6.0338959
GSM549142patient 047, cancer, homogenized [OPG study]5.3105544
GSM549100patient 110, normal, homogenized [OPG study]5.0654241
GSM549107patient 135, normal, homogenized [OPG study]5.4887150
GSM549115patient 068, normal, homogenized [OPG study]5.6401353
GSM549116patient 072, normal, homogenized [OPG study]5.5262151
GSM549120patient 078, normal, homogenized [OPG study]5.0720942
GSM549131patient 030, cancer, homogenized [OPG study]5.6538753
GSM549118patient 074, normal, homogenized [OPG study]4.9479839
GSM549129patient 027, cancer, homogenized [OPG study]5.7914954
GSM549123patient 088, normal, homogenized [OPG study]5.0417841
GSM549124patient 006, cancer, homogenized [OPG study]5.5497250
GSM549126patient 015, cancer, homogenized [OPG study]5.4957850
GSM549128patient 025, cancer, homogenized [OPG study]5.9485557
GSM549103patient 117, normal, homogenized [OPG study]5.1023741
GSM549117patient 073, normal, homogenized [OPG study]5.4442650
GSM549138patient 041, cancer, homogenized [OPG study]6.4766465
GSM549141patient 045, cancer, homogenized [OPG study]5.6619753
GSM549130patient 028, cancer, homogenized [OPG study]5.6219552
GSM549101patient 111, normal, homogenized [OPG study]5.2214544
GSM549105patient 128, normal, homogenized [OPG study]5.3491847
GSM549106patient 134, normal, homogenized [OPG study]4.9987741
GSM549112patient 048, normal, homogenized [OPG study]5.1136943
GSM549125patient 011, cancer, homogenized [OPG study]5.7541554
GSM549127patient 024, cancer, homogenized [OPG study]5.2710246
GSM549135patient 035, cancer, homogenized [OPG study]5.4516349